1-12 of 12
Matthew Cortese
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact of sequencing of CART vs bi-specific antibody on survival in relapsed/refractory large B-cell lymphoma: An analysis from the ABC consortium

Free
Max Kelsten, Colin Thomas, Yun Kyoung Tiger, Ari Pelcovits, Adam Kidwell, Matthew Cortese, James Davis, Deborah Stephens, Tamara Moyo, Lindsey Fitzgerald, Jonathon Cohen, Megan Melody, Vaishalee Kenkre, Brian Hess, Megan Herr, Geoffrey Shouse, Thomas Ollila, Daniel Antonio, Alexandra Noveihed, Omar Elghawy, Alan Kerr, Jonathan Moreira, Shuo Ma, Jane Winter, Nirav Shah, Leo Gordon, Narendranath Epperla, Natalie Grover, Reem Karmali
Journal: Blood
Blood (2025) 146 (Supplement 1): 398.
https://doi.org/10.1182/blood-2025-398
Published: 2025
Journal Articles

Comparison of infections in patients with chronic lymphocytic leukemia (CLL) treated with BTKi versus venetoclax obinutuzumab in first line therapy

Free
Jawria Tufail, Zubair Hassan Bodla, Matthew Cortese, Muhammad Junaid Tariq
Journal: Blood
Blood (2025) 146 (Supplement 1): 3884.
https://doi.org/10.1182/blood-2025-3884
Published: 2025
Journal Articles

Bispecific antibody vs non-bispecific antibody systemic therapy as immediate next line treatment after chimeric antigen receptor T-cell (CART) failure in large B-cell lymphoma

Free
Kyle Miyazaki, Natalie Grover, Colin Thomas, Yun Kyoung Tiger, Ari Pelcovits, Matthew Cortese, James Davis, Adam Kidwell, Tamara Moyo, Lindsey Fitzgerald, Jonathon Cohen, Megan Melody, Vaishalee Kenkre, Megan Herr, Thomas Ollila, Geoffrey Shouse, Daniel Antonio, Deborah Stephens, Nirav Shah, Nour Nassour, Omar Elghawy, Jonathan Moreira, Adit Dharia, Salmaan Mubeen, Shuo Ma, Jane Winter, Leo Gordon, Brian Hess, Narendranath Epperla, Reem Karmali
Journal: Blood
Blood (2025) 146 (Supplement 1): 4502.
https://doi.org/10.1182/blood-2025-4502
Published: 2025
Journal Articles

Evaluation of outcomes and toxicities of loncastuximab tesirine (Lonca) in relapse/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL): Real-world data analysis (RWDA) from 10 US academic centers

Free
Alex Niu, Alan Hutson, Joseph Parker, Muhamad Alhaj Moustafa, Sherwin Kelekar, Yasmin Karimi, Arshed Al-Obeidi, Natalie Grover, Allison Bock, Kelsey Baron, Narendranath Epperla, Suheil Albert Atallah-Yunes, Yucai Wang, Talal Hilal, Catherine Reinert, Ajay Major, Megan Sears-Smith, Nilanjan Ghosh, Meghana Subramanian, Yun Kyoung Tiger, Matthew Cortese, Francisco Hernandez-Ilizaliturri
Journal: Blood
Blood (2025) 146 (Supplement 1): 4514.
https://doi.org/10.1182/blood-2025-4514
Published: 2025
Journal Articles

Real-world outcomes with bispecific antibody therapies for aggressive B-cell lymphomas in octogenarians

Free
Lindsey Fitzgerald, Elena Nazarenko, Yizhe Xu, Natalie Grover, Colin Thomas, Yun Kyoung Tiger, Ari Pelcovits, Matthew Cortese, James Davis, Adam Kidwell, Tamara Moyo, Kyle Miyazaki, Jonathon Cohen, Megan Melody, Daniel Kerr, Vaishalee Kenkre, Thomas Ollila, Megan Herr, Salmaan Mubeen, Geoffrey Shouse, Daniel Antonio, Deborah Stephens, Nirav Shah, Jonathan Moreira, Shuo Ma, Jane Winter, Leo Gordon, Brian Hess, Reem Karmali, Narendranath Epperla
Journal: Blood
Blood (2025) 146 (Supplement 1): 3746.
https://doi.org/10.1182/blood-2025-3746
Published: 2025
Journal Articles

Outcomes of patients with Relapsed/Refractory aggressive B-cell lymphoma receiving bispecific antibody therapy as monotherapy or in combination with targeted therapy

Free
Timothy Oh, Ari Pelcovits, Natalie Grover, Colin Thomas, Yun Kyoung Tiger, Matthew Cortese, James Davis, Adam Kidwell, Tamara Moyo, Lindsey Fitzgerald, Jonathon Cohen, Megan Melody, Nikesh Shah, Vaishalee Kenkre, Brian Hess, Thomas Ollila, Megan Herr, Geoffrey Shouse, Salmaan Mubeen, Omar Elghawy, Daniel Antonio, Daniel Kerr, Calvin Lee, Jonathan Moreira, Shuo Ma, Jane Winter, Nirav Shah, Leo Gordon, Narendranath Epperla, Deborah Stephens, Reem Karmali
Journal: Blood
Blood (2025) 146 (Supplement 1): 4551.
https://doi.org/10.1182/blood-2025-4551
Published: 2025
Journal Articles

Socioeconomic disadvantage, as measured by area deprivation index (ADI), impacts survival in patients with relapsed/refractory aggressive lymphoma treated with CART

Free
Daniel Antonio, Tarneka Manning, Natalie Grover, Colin Thomas, Ari Pelcovits, Matthew Cortese, James Davis, Tamara Moyo, Lindsey Fitzgerald, Jonathon Cohen, Vaishalee Kenkre, Megan Herr, Deborah Stephens, Geoffrey Shouse, Jonathan Moreira, Shuo Ma, Jane Winter, Leo Gordon, Brian Hess, Narendranath Epperla, Reem Karmali
Journal: Blood
Blood (2025) 146 (Supplement 1): 6281.
https://doi.org/10.1182/blood-2025-6281
Published: 2025
Journal Articles

Risk factors for CRS and NT with bispecific antibodies: Data from the American bispecifics and CART (ABC) consortium

Free
Victoria Gill, Ari Pelcovits, Thomas Ollila, Lindsey Fitzgerald, Narendranath Epperla, Natalie Grover, Colin Thomas, Yun Kyoung Tiger, Alexandra Noveihed, Matthew Cortese, James Davis, Adam Kidwell, Tamara Moyo, Kyle Miyazaki, Jonathon Cohen, Megan Melody, Adit Dharia, Vaishalee Kenkre, Megan Herr, Geoffrey Shouse, Daniel Antonio, Deborah Stephens, Nirav Shah, Jonathan Moreira, Shuo Ma, Jane Winter, Leo Gordon, Brian Hess, Reem Karmali
Journal: Blood
Blood (2025) 146 (Supplement 1): 960.
https://doi.org/10.1182/blood-2025-960
Published: 2025
Journal Articles

Polatuzumab vedotin in combination with rituximab, cyclophosphamide, doxorubicin and prednisone (Pola R+CHP) results in similar clinical outcomes than rituximab and dose adjusted etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin (R+DA-EPOCH) in patients with high-risk features diffuse large B-cell lymphoma (DLBCL): A single institution experience.

Free
Rahul Thakur, Han Yu, Mariam Haji, Vaishali Deenadayalan, Vasanthan Kumarasamy, Ajinkya Buradkar, Jordan Scott, Grant Schofield, Dorothy Pan, Matthew Cortese, Francisco Hernandez-Ilizaliturri, Alex Niu
Journal: Blood
Blood (2025) 146 (Supplement 1): 3685.
https://doi.org/10.1182/blood-2025-3685
Published: 2025
Journal Articles

Infections in patients with aggressive B-cell lymphomas treated with CD3xCD20 bispecific antibodies

Free
Daniel Reef, Nicole Altomare, Colin Thomas, Salmaan Mubeen, Yun Kyoung Tiger, Ari Pelcovits, Thomas Ollila, Victoria Gill, Adam Kidwell, Matthew Cortese, James Davis, Deborah Stephens, Tamara Moyo, Lindsey Fitzgerald, Jonathon Cohen, Adit Dharia, Megan Melody, Vaishalee Kenkre, Brian Hess, Megan Herr, Geoffrey Shouse, Nirav Shah, Narendranath Epperla, Tessa Andermann, Reem Karmali, Natalie Grover
Journal: Blood
Blood (2025) 146 (Supplement 1): 2709.
https://doi.org/10.1182/blood-2025-2709
Published: 2025
Journal Articles

Real world comparison of commercial CAR T-cell constructs for the treatment of LBCL

Free
Megan Melody, Alan Kerr, Megan Herr, Adit Dharia, Nicole Altomare, Natalie Grover, Colin Thomas, Omar Elghawy, Yun Kyoung Tiger, Alexandra Noveihed, Ari Pelcovits, Thomas Ollila, Matthew Cortese, James Davis, Adam Kidwell, Tamara Moyo, Lindsey Fitzgerald, Jonathon Cohen, Nikesh Shah, David Swoboda, Vaishalee Kenkre, Geoffrey Shouse, Daniel Antonio, Deborah Stephens, Nirav Shah, Jonathan Moreira, Shuo Ma, Jane Winter, Leo Gordon, Narendranath Epperla, Reem Karmali, Brian Hess
Journal: Blood
Blood (2025) 146 (Supplement 1): 781.
https://doi.org/10.1182/blood-2025-781
Published: 2025
Journal Articles

Multiomic correlates of ex vivo αCD19 chimeric antigen receptor T-cell (CART) cytotoxicity in venetoclax-treated patients with chronic lymphocytic leukemia (CLL)

Free
Jacob Wright, Francisco Hernandez-Ilizaliturri, Cory Mavis, Joseph Tario, Alex Niu, Taylor Mandeville, Dorothy Pan, Grant Schofield, Dae-Kyum Kim, Joseph Barbi, Hua-Hsin Hsiao, Spencer Rosario, Matthew Cortese
Journal: Blood
Blood (2025) 146 (Supplement 1): 5661.
https://doi.org/10.1182/blood-2025-5661
Published: 2025